| | Business Summary | | Illumina,
Inc.
is
a
developer
of
next-generation
tools
for
the
large-scale
analysis
of
genetic
variation
and
function.
Its
patented
BeadArray
technology
uses
fiber
optics
to
achieve
a
level
of
array
miniaturization
that
allows
for
a
new
scale
of
experimentation.
Its
complementary
Oligator
technology
permits
parallel
synthesis
of
the
millions
of
different
pieces
of
DNA
necessary
to
perform
large-scale
genetic
analysis
on
arrays.
An
array
is
a
collection
of
miniaturized
test
sites
arranged
on
a
surface
that
permits
many
tests,
or
assays,
to
be
performed
in
parallel.
The
Company's
proprietary
manufacturing
process
allows
it
to
easily
adapt
the
arrays
to
a
broad
range
of
applications.
These
advances
allow
the
Company
to
create
next-generation
arrays
with
a
combination
of
high-throughput,
cost
effectiveness
and
flexibility. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Illumina,
Inc.
develops
next-generation
tools
for
the
large-scale
analysis
of
genetic
variation
and
function
and
provides
information
that
could
be
used
to
improve
drugs
and
therapies
and
cure
disease.
For
the
six
months
ended
6/30/01,
revenues
totalled
$1
million,
up
from
$162
thousand.
Net
loss
rose
7%
to
$10.8
million.
Revenues
reflect
an
increase
in
government
grants.
Higher
loss
reflects
an
increase
in
salaries
and
other
personnel-related
expenses. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Jay Flatley, 48
Pres,
CEO, Director | $408K | Timothy Kish, 49
CFO,
VP | 196K | David Barker, Ph.D., 59
VP,
CSO | 175K | Mark Chee, Ph.D., 39
VP
of Genomics | 171K | David Douglas, 46
VP,
Manufacturing | -- | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/i/ilmn.gif)